Azacitadine Demonstrates Efficacy in a Phase 2 Trial of PTCL
December 18th 2020Jia Ruan, MD, PhD, discusses the results of the multicenter phase 2 trial of oral azacitidine plus cyclophosphamide, doxorubicin, vincristine, and prednisone as initial treatment in patients with peripheral T-cell lymphoma.